Mismatch Negativity Latency As a Biomarker of Amnestic Mild Cognitive Impairment in Chinese Rural Elders

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2015 Mar 28

PMID 25814949

Citations 10

Authors

Li-Li Ji

Yuan-Yuan Zhang

Lane Zhang

Bing He

Guo-Hua Lu

Affiliations

Soon will be listed here.

Abstract

The aim was to evaluate the mismatch negativity (MMN) component, a correlate of the automatic detection of changes in the acoustic environment, in healthy adults, and adults with amnestic mild cognitive impairment (aMCI). Forty-three aMCI subjects and 43 healthy Chinese older adults were arranged into experimental group and control group, respectively. Their MMN amplitude and latency were measured at the FZ, FCZ, and CZ electrode sites under a passive auditory oddball task. The results showed that the latencies obtained from the FZ, FCZ, and CZ electrode sites were significantly longer in the aMCI adults than in the control adults (P < 0.01) while there were no significant differences in MMN amplitude between two groups (P > 0.05). The MMN latency was found to be a sensitive and specific biomarker of aMCI.

Citing Articles

Transient changes in mismatch negativity after two sessions of electroconvulsive therapy for atypical psychosis: A case report.

Mori Y, Kanno K, Hoshino H, Takahashi Y, Suzuki Y, Miura I PCN Rep. 2024; 3(3):e233.

PMID: 39135780 PMC: 11317306. DOI: 10.1002/pcn5.233.

Altered auditory processes pattern predicts cognitive decline in older adults: different modalities with aging.

Yang J, Tang X, Lin S, Jiang L, Wei K, Cao X Front Aging Neurosci. 2023; 15:1230939.

PMID: 37736326 PMC: 10510405. DOI: 10.3389/fnagi.2023.1230939.

The mismatch negativity as an index of cognitive abilities in adults with Down syndrome.

Saini F, Masina F, Wells J, Rosch R, Hamburg S, Startin C Cereb Cortex. 2023; 33(16):9639-9651.

PMID: 37401006 PMC: 10431748. DOI: 10.1093/cercor/bhad233.

mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [C]ABP688 PET/MR-EEG.

Regio Brambilla C, Veselinovic T, Rajkumar R, Mauler J, Matusch A, Ruch A Transl Psychiatry. 2022; 12(1):6.

PMID: 35013095 PMC: 8748790. DOI: 10.1038/s41398-021-01763-3.

Investigating Auditory Electrophysiological Measures of Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Event-Related Potential Studies.

Tarawneh H, Mulders W, Sohrabi H, Martins R, Jayakody D J Alzheimers Dis. 2021; 84(1):419-448.

PMID: 34569950 PMC: 8609695. DOI: 10.3233/JAD-210556.

References

Tales A, Haworth J, Wilcock G, Newton P, Butler S . Visual mismatch negativity highlights abnormal pre-attentive visual processing in mild cognitive impairment and Alzheimer's disease. Neuropsychologia. 2008; 46(5):1224-32. DOI: 10.1016/j.neuropsychologia.2007.11.017. View

Gaeta H, Friedman D, Ritter W, Cheng J . An event-related potential study of age-related changes in sensitivity to stimulus deviance. Neurobiol Aging. 1999; 19(5):447-59. DOI: 10.1016/s0197-4580(98)00087-6. View

Small G, Kepe V, Ercoli L, Siddarth P, Bookheimer S, Miller K . PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med. 2006; 355(25):2652-63. DOI: 10.1056/NEJMoa054625. View

Wijnen V, van Boxtel G, Eilander H, De Gelder B . Mismatch negativity predicts recovery from the vegetative state. Clin Neurophysiol. 2007; 118(3):597-605. DOI: 10.1016/j.clinph.2006.11.020. View

Roberts R, Geda Y, Knopman D, Cha R, Pankratz V, Boeve B . The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology. 2012; 78(5):342-51. PMC: 3280046. DOI: 10.1212/WNL.0b013e3182452862. View

Jia J, Zhou A, Wei C, Jia X, Wang F, Li F . The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement. 2014; 10(4):439-447. DOI: 10.1016/j.jalz.2013.09.008. View

Lindin M, Correa K, Zurron M, Diaz F . Mismatch negativity (MMN) amplitude as a biomarker of sensory memory deficit in amnestic mild cognitive impairment. Front Aging Neurosci. 2013; 5:79. PMC: 3834246. DOI: 10.3389/fnagi.2013.00079. View

Nagai T, Tada M, Kirihara K, Araki T, Jinde S, Kasai K . Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review. Front Psychiatry. 2013; 4:115. PMC: 3779867. DOI: 10.3389/fpsyt.2013.00115. View

Petersen R, Smith G, Waring S, Ivnik R, Tangalos E, Kokmen E . Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999; 56(3):303-8. DOI: 10.1001/archneur.56.3.303. View

10.

Kasten M, Bruggemann N, Schmidt A, Klein C . Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2010; 75(5):478. DOI: 10.1212/WNL.0b013e3181e7948a. View

11.

Brookmeyer R, Gray S, Kawas C . Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998; 88(9):1337-42. PMC: 1509089. DOI: 10.2105/ajph.88.9.1337. View

12.

Perneczky R, Tsolakidou A, Arnold A, Diehl-Schmid J, Grimmer T, Forstl H . CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease. Neurology. 2011; 77(1):35-8. DOI: 10.1212/WNL.0b013e318221ad47. View

13.

Kathmann N, Wagner M, Rendtorff N, Engel R . Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics. Biol Psychiatry. 1995; 37(10):754-7. DOI: 10.1016/0006-3223(94)00309-Q. View

14.

Hoops S, Nazem S, Siderowf A, Duda J, Xie S, Stern M . Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009; 73(21):1738-45. PMC: 2788810. DOI: 10.1212/WNL.0b013e3181c34b47. View

15.

Stephan B, Minett T, Pagett E, Siervo M, Brayne C, McKeith I . Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review. BMJ Open. 2013; 3(2). PMC: 3586181. DOI: 10.1136/bmjopen-2012-001909. View

16.

Bischkopf J, Busse A, Angermeyer M . Mild cognitive impairment--a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand. 2002; 106(6):403-14. DOI: 10.1034/j.1600-0447.2002.01417.x. View

17.

Mowszowski L, Hermens D, Diamond K, Norrie L, Hickie I, Lewis S . Reduced mismatch negativity in mild cognitive impairment: associations with neuropsychological performance. J Alzheimers Dis. 2012; 30(1):209-19. DOI: 10.3233/JAD-2012-111868. View

18.

Hamalainen A, Pihlajamaki M, Tanila H, Hanninen T, Niskanen E, Tervo S . Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol Aging. 2006; 28(12):1889-903. DOI: 10.1016/j.neurobiolaging.2006.08.008. View

19.

Zhang Z, Deng L, Yu H, Shi Y, Bai F, Xie C . Association of angiotensin-converting enzyme functional gene I/D polymorphism with amnestic mild cognitive impairment. Neurosci Lett. 2012; 514(1):131-5. DOI: 10.1016/j.neulet.2012.02.074. View

20.

Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View